Computer Science ›› 2026, Vol. 53 ›› Issue (5): 337-345.doi: 10.11896/jsjkx.250300168

• Artificial Intelligence • Previous Articles     Next Articles

Study on Drug Target Affinity Prediction Based on Multi-view Comparison and Homology Information

TIAN Xin1, ZHU Guosheng1, XIONG Yuran1, WU You2   

  1. 1 School of Computer Science, Hubei University, Wuhan 430062, China
    2 School of Cyber Science and Technology, Hubei University, Wuhan 430062, China
  • Received:2025-03-31 Revised:2025-06-19 Published:2026-05-08
  • About author:TIAN Xin,born in 2000,postgraduate.His main research interests include bioinformatics and graph contrast lear-ning.
    ZHU Guosheng,born in 1972,Ph.D,professor,is a member of CCF(No.D4728M).His main research interests include bioinformatics and machine learning.
  • Supported by:
    CERNET Innovation Project(NGI20180411).

Abstract: Existing graph neural network(GNN)-based methods for drug-target affinity(DTA) prediction exhibit notable limitations in feature utilization and view alignment.Specifically,1) they fail to sufficiently model the feature representations of drugs and proteins within their respective views,leading to incomplete intra-view feature learning and restricted exploitation of feature information;2) they are unable to effectively align the intrinsic correlations across different views,thereby limiting cross-view information synergy.To address these challenges,a MVHGNN(Multi-View Hybrid Homogeneous Graph Neural Network ) is proposed.MVHGNN constructs a multi-view contrastive learning framework,employing an ESTGCN(Enhanced Subgraph Topology Graph Convolutional Network) and a GIN(Graph Isomorphism Network) as encoders in the drug molecular view and protein view,respectively,to capture the topological and hierarchical features of drugs and proteins.Furthermore,homology information is integrated to enhance intra-view feature representation and utilization.In the drug-target affinity view,a GCN(Graph Convolutional Network) is used to extract global topological information,enabling the construction of drug-protein interaction representations.A cross-view contrastive learning strategy is further adopted to maximize mutual information between drugs and proteins across different views,enhancing representation consistency and cross-view collaboration.Experimental results demonstrate that MVHGNN achieves superior performance on two benchmark datasets,notably reaching a mean squared error(MSE)of 0.166 and a modified determination coefficient(r2m) of 0.794 on the Davis dataset,outperforming existing state-of-the-art methods.

Key words: Multi-view contrastive learning, Topological features, Homology information, Drug-target affinity(DTA), Cross-view contrastive learning

CLC Number: 

  • TP391
[1]HASSANI K,KHASAHMADI A H.Contrastive multi-viewrepresentation learning on graphs[C]//Proceedings of the 37th International Conference on Machine Learning.PMLR,2020:4116-4126.
[2]CHEN R,CHEN J,GAN X,et al.Multi-View Graph Contrastive Learning for Social Recommendation[J].Scientific Reports,2024,14:22643.
[3]VELIČKOVIĆ P,FEDUS W,HAMILTON W L,et al.Deep graph infomax[J].arXiv:1809.10341,2018.
[4]CHEN T,KORNBLITH S,NOROUZI M,et al.A simpleframework for contrastive learning of visual representations[C]//Proceedings of the 37th International Conference on Machine Learning.PMLR,2020:1597-1607.
[5]GRILL J B,STRUB F,ALTCHÉ F,et al.Bootstrap your own latent:A new approach to self-supervised learning[J].arXiv:2006.07733,2020.
[6]QIU J,CHEN Q,DONG Y.GCC:Graph contrastive coding for graph neural network pre-training[C]//Proceedings of the 26th ACM SIGKDD International Conference on Knowledge Disco-very & Data Mining.ACM,2020:1150-1160.
[7]XIONG Z,LIU S,HUANG F.Multi-relational contrastivelearning graph neural network for drug-drug interaction event prediction[C]//Proceedings of the AAAI Conference on Artificial Intelligence.AAAI,2023:5339-5347.
[8]CHENG Z,ZHONG T,ZHANG K.Learning co-ntrastive multi-view graphs for recommendation(student abstract)[C]//Proceedings of the AAAI Conference on Artificial Intelligence.AAAI,2022:12927-12928.
[9]ZHANG L,OUYANG C,LIU Y,et al.Multimodal contrastive representation learning for drug-target binding affinity prediction[J].Methods,2023,220:126-133.
[10]LI Z,REN P,YANG H,et al.TEFDTA:A transformer encoder and fingerprint representation combined prediction method for bonded andnon-bonded drug-target affinities[J].Bioinformatics,2024,40(1):btad778.
[11]GILSON M K,LIU T,BAITALUK M,et al.Binding DB in2015:A public database for medicinal chemistry,computational chemistry and systems pharmacology[J].Nucleic Acids Research,2015,44:D1045-D1053.
[12]KIM S,CHEN J,CHENG T,et al.PubChem 2019 update:Improved access to chemical data[J].Nucleic Acids Research,2018,47:D1102-D1109.
[13]TSUBAKI M,TOMII K,SESE J,et al.Compound-protein interaction prediction with end-to-end learning of neural networks for graphs and sequences[J].Bioinformatics,2018,35(2):309-318.
[14]GHOSH P,HAQUE M A.ResDTA:Predicting drug-targetbinding affinity using residual skip connections[J].arXiv:2303.11434,2023.
[15]VELIČKOVIĆ P,CUCURULL,G,CASANOVA A,et al.Graph Attention Networks[J].arXiv:1710.10903,2018.
[16]WU H J,LIU J K,JIANG T S,et al.AttentionMGT-DTA:A multi-modal drug-target affinity prediction using graph transformer and attention mechanism[J].Neural Networks,2024,169:623-636.
[17]ÖZTÜRK H,ÖZGÜR A,ÖZKI·RIMLI E,et al.DeepDTA:Deep drug target binding affinity prediction[J].Bioinforma-tics,2018,34(17):i821-i829.
[18]NGUYEN T,LE H,QUINN T P,et al.GraphDTA:Predicting drug-target binding affinity with graph neural networks[J].Bioinformatics,2021,37(8):1140-1147.
[19]WANG R Z,ZHANG Y Q,QIN Q Q,et al.Multi-aspect multi-attention fusion of molecular features for drug-target affinity prediction[J].Journal of Computer Applications,2022,42(1):325-332.
[20]ZHAO Q,DUAN G,YANG M,et al.AttentionDTA:Drug-target binding affinity prediction by sequence-based deep learning with attention mechanism[J].IEEE/ACM Transactions on Computational Biology and Bioinformatics,2023,20(2):852-863.
[21]WANG J,XIAO Y,SHANG X,et al.Predicting drug-targetbinding affinity with cross-scale graph contrastive learning[J].Briefings in Bioinformatics,2024,25(1):bbad516.
[22]GUO M H,LIU Z N,MU T J,et al.Beyond Self-Attention:External Attention Using Two Linear Layers for Visual Tasks[J].IEEE Transactions on Pattern Analysis and Machine Intelligence,2023,45(5):5436-5447.
[23]BOLTON E E,WANG Y,THIESSEN P A,et al.PubChem:Integrated platform of small molecules and biological activities[J].Annual Reports Computational Chemistry,2008,4:217-241.
[24]SMITH T F,WATERMAN M S.Identification of common molecular subsequences[J].Journal of Molecular Biology,1981,147(1):195-197.
[25]OORD A,LI Y,VINYALS O,et al.Representation learningwith contrastive predictive coding[J].arXiv:1807.03748,2018.
[26]DAVIS M I,HUNT J P,HERRGARD S,et al.Comprehensive analysis of kinase inhibitor selectivity[J].Nature Biotechnology,2011,29(11):1046-1051.
[27]TANG J,SZWAJDA A,SHAKYAWAR S,et al.Making sense of large-scale kinase inhibitor bioactivity data sets:A comparative and integrative analysis[J].Journal of Chemical Information and Modeling,2014,54(3):735-743.
[28]HE T,HEIDEMEYER M,GN F,et al.SimBoost:A read-across approach for predicting drug-target binding affinities using gradient boosting machines[J].Journal of Chemistry,2017,9(1):24.
[29]LOVRIĆ M,MOLERO J M,KERN R,et al.PySpark and RDKit:Movingtowards big data in cheminformatics[J].Molecular Informatics,2019,38(6):e1800082.
[30]MICHEL M,HURTADO D M,ELOFSSON A,et al.PconsC4:Fast,accurate and hassle-free contact predictions[J].Bioinformatics,2019,35(15):2677-2679.
[31]JIANG M,LI Z,ZHANG S,et al.Drug-target affinity prediction using graph neural network and contact maps[J].RSC Advances,2020,10(35):20701-20712.
[32]YUAN W,CHEN G,CHEN C,et al.FusionDTA:Attention-based feature polymerizer and knowledge distillation for drug-target binding affinity prediction[J].Briefings inBioinforma-tics,2022,23(1):bbab506.
[33]CHU Z,HUANG F,FU H,et al.Hierarchical graph representation learning for the prediction of drug-target binding affinity[J].Information Sciences,2022,613:507-523.
[34]LI M,GUO Z,WU Y,et al.ViDTA:Enhanced drug-target affi-nity prediction via virtual graph nodes and attention-based feature fusion[J].arXiv:2412.19589,2024.
[35]LI J,YAO L.HCAF-DTA:Drug-target binding affinity prediction with cross-attention fused hypergraph neural networks[J].arXiv:2504.02014,2025.
[36]ROY K,CHAKRABORTY P,MITRA I,et al.Some case stu-dies on application of “r2m” metrics for judging quality of quantitative structure-activity relationship predictions:Emphasis on scaling of response data[J].Journal of Computational Chemistry,2013,34:1071-1082.
[1] WANG Hui, LE Zi-chun, GONG Xuan, ZUO Hao, WU Yu-kun. TNTlink Prediction Model Based on Feature Learning [J]. Computer Science, 2020, 47(12): 245-251.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!